Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

NGNENGNE
10 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in NEUROGENE INC

NORTHERN TRUST CORP holds 103,641 shares of NGNE (NEUROGENE INC), worth $3.3M as of 2026-Q2. The position was increased (+6.2% shares). NGNE represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$3.3M

Current Shares

103,641

Total Value Change

+$2.1M

Total Shares Change

+81,006

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
103,641
+6.2%
$3.3M0.0%$31.45
28
2026-Q1
Increased
97,621
+14.1%
$2M0.0%$21.99
29
2025-Q4
Decreased
85,559
-5.0%
$1.8M0.0%$22.11
0
2025-Q3
Decreased
90,098
-3.3%
$1.6M0.0%$17.71
0
2025-Q2
Decreased
93,171
-15.6%
$1.4M0.0%$16.16
0
2025-Q1
Increased
110,410
+9.8%
$1.3M0.0%$14.52
28
2024-Q4
Increased
100,566
+6.2%
$2.3M0.0%$22.28
28
2024-Q3
Increased
94,721
+229.6%
$4M0.0%$40.33
43
2024-Q2
Increased
28,739
+27.0%
$1M0.0%$36.39
31
2024-Q1
New
22,635
-
$1.2M0.0%$50.90
35

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used